Author Question: A visual interneuron's receptive field is defined as the a. portion of the visual field to which ... (Read 39 times)

bio_gurl

  • Hero Member
  • *****
  • Posts: 524
A visual interneuron's receptive field is defined as the
 
  a. portion of the visual field to which the interneuron responds.
 b. group of photoreceptors providing the interneuron with input.
 c. combination of the interneuron and the cells with which it communicates.
 d. location on the retina where light affects the interneuron's activity.

Question 2

Michael is determined to lose 50 pounds. In addition to looking and feeling great, what else should Michael expect?
 
  a. His reactions to hot and cold weather will not change due to his weight loss.
  b. He will feel warmer than before in hot weather.
 c. He will feel warmer than before in cold weather.
 d. He will feel cooler than he did before in both warm and cold weather.



ricroger

  • Sr. Member
  • ****
  • Posts: 352
Answer to Question 1

d

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

About 100 new prescription or over-the-counter drugs come into the U.S. market every year.

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library